Keywords: Stable gastric pentadecapeptide BPC 157 therapy, Roberts cytoprotection, Adaptive cytoprotection, Organoprotection concept, Mediator INTRODUCTION Stable gastric pentadecapeptide BPC 157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis, lethal dose (dosage required to kill 1% of the test population, LD1) not reported
Lipotropic injections are intramuscular infusions of methionine, inositol, choline (MIC), and B12
Patients who combine semaglutide GLP-1 therapy with balanced nutrition, regular physical activity, and consistent medical monitoring often see more reliable progress
Foods Basel Switz 11:4016 Sakuma S et al (2022) Comparative effects of sulforaphane and allyl isothiocyanate on 3T3-L1 adipogenesis